Bronchodilator reversibility testing in morbidly obese non-smokers: a comparative study– few concerns
Abstract This is a letter in response to an article by Ahmed et al., which concluded that in comparison to salbutamol, Fluticasone/salmeterol combination increases FEV1, FEV1% of predicted, and FEV1/FVC ratio, however it did not offer novel insights, as both agents met the 12%- and 200-mL reversibil...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-03-01
|
| Series: | BMC Pulmonary Medicine |
| Online Access: | https://doi.org/10.1186/s12890-024-02951-9 |